logo

Merck & Co Inc. (MRK)



Trade MRK now with
  Date
  Headline
3/25/2019 10:57:34 AM S&P 500 Q4 Share Repurchases Increases 62.8% T-o-y To $223.0 Bln
3/20/2019 6:33:14 AM Merck, NGM Bio Extend Broad, Multi-Year Strategic Collaboration To 2022
3/18/2019 8:03:47 AM Merck: Health Canada Expands Label For KEYTRUDA For NSCLC, With Pemetrexed And Platinum Chemotherapy
3/14/2019 6:48:16 AM EU Approves Merck’s KEYTRUDA In Combination With Chemotherapy For First-Line Treatment Of Adults With NSCLC
3/5/2019 7:01:20 AM Merck Begins Cash Tender Offer To Purchase Immune Design
3/4/2019 6:48:33 AM Merck Says EMA Adopts Positive Opinion For KEYTRUDA Anti-PD-1 Therapy
2/21/2019 6:47:54 AM Merck To Acquire Immune Design For $5.85/Shr Cash
2/20/2019 6:48:05 AM FDA Grants Priority Review To Merck's SBLA For KEYTRUDA Monotherapy